Keywords: amarillo, bio, commercialize, low-dose, interferon, se, asia

Amarillo Bio to commercialize low-dose interferon in SE Asia

Article | 05 December 2005

Print This

Texas, USA-based Amarillo Biosciences says that it has entered into an agency agreement with Claus Martin, chief executive of Gesellschaft ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in